Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Interaction of Chlorthalidone and Losartan Fixed Combination
NCT05090449Phase 1Completed
- Sponsor
- Laboratorios Silanes
- Start
- May 2019
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of chlorthalidone and losartan in hypertension (HTN) (4 arms), sponsored by Laboratorios Silanes. Primary endpoints: Maximum observed concentration, Area under the curve from time zero to last measurable concentration and 3 more. Started May 2019; status: completed.
02
Drugs
chlorthalidonelosartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT05090449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05090449.